Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level DNarrative ReviewPubMed
Needles for healing: stem cells, platelet-enriched plasma, and fat injection in perianal fistulizing Crohn's disease.
Narrative Review on Chronic Wound, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Tech Coloproctol (2026) — summary generated from the PubMed abstract.
- 2026
Tech Coloproctol - Level DNarrative ReviewEurope PMC
Perianal Fistulizing Crohn's Disease: Outcomes of Surgical Repairs and Current State of Stem Cell-Based Therapies
Narrative Review on Autoimmune Research, published in Clin Colon Rectal Surg (2025) — summary generated from the PubMed abstract.
- 2025
Clin Colon Rectal Surg - Level DNarrative ReviewEurope PMC
Management and Treatment of Perianal Fistulizing Crohn's Disease
Narrative Review on Autoimmune Research, published in Clin Exp Gastroenterol (2025) — summary generated from the PubMed abstract.
- 2025
Clin Exp Gastroenterol - Level BClinical TrialEurope PMC
Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives
Clinical Trial on Autoimmune Research, published in BioDrugs (2024) — summary generated from the PubMed abstract.
- 2024
BioDrugs10 citations - Level BClinical TrialPubMed
Adipose tissue-derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease.
Clinical Trial with a reported sample of 3 on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in J Cell Physiol (2022) — summary generated from the PubMed abstract.
- 2022
- n = 3
J Cell Physiol - Level CProspective StudyPubMed
Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T-cell immunosuppressive capacity.
Prospective Study on Immune Modulation, Autoimmune Research, published in J Cell Mol Med (2022) — summary generated from the PubMed abstract.
- 2022
J Cell Mol Med - Level BClinical TrialPubMed
Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas.
Clinical Trial with a reported sample of 5 on Autoimmune Research, published in Inflamm Bowel Dis (2020) — summary generated from the PubMed abstract.
- 2020
- n = 5
Inflamm Bowel Dis - Level DAnimal StudyPubMed
Mesenchymal stem cells and acellular products attenuate murine induced colitis.
Animal Study on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cell Res Ther34 citations - Level BClinical TrialPubMed
Stem cell therapy for perianal Crohn's.
Clinical Trial with a reported sample of 300 on Autoimmune Research, published in Curr Opin Gastroenterol (2019) — summary generated from the PubMed abstract.
- 2019
- n = 300
Curr Opin Gastroenterol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406